Effect of intravitreal bevacizumab based on optical coherence tomography patterns of diabetic macular edema

Ophthalmologica

Volumn 226, Issue 3, 2011, Pages 138-144

  Kim, Moosang ^a   Lee, Pyung ^b   Kim, Younggyun ^c   Yu, Seung Young ^b   Kwak, Hyung Woo ^b  

^a Inje University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

^c Eulji University   (South Korea)

Author keywords

Bevacizumab; Diabetic macular edema; Optical coherence tomography

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; DIABETIC MACULAR EDEMA; DIFFUSE RETINAL THICKENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; SEROUS RETINAL DETACHMENT; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 80053110963     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000330045     Document Type: Article

References (32)

1. Gaudric A, Massin-Korobelnik P: Diabetic maculopathy: classification, epidemiology, spontaneous outcome, treatment. Diabetes Metab 1993; 19: 422-429.
2. Early Treatment Diabetic Retinopathy Study research group: Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985; 103: 1796-1806.
3. Early Treatment Diabetic Retinopathy Study Research Group: Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 1987; 94: 761-774
4. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S: Vitreous levels of interleukin-and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2003; 110: 1690-1696. (Pubitemid 37025424)
5. Funatsu H, Yamashita H, Sakata K, Noma H, Mimura T, Suzuki M, Eguchi S, Hori S: Vitreous levels of vascular endothelial growth factor and intracellular adhesion molecule 1 are related to diabetic macular edema. Ophthalmology 2005; 112: 806-816. (Pubitemid 40631499)
6. Jonas JB, Kreissig I, Sofker A, Degenring RF: Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57-61. (Pubitemid 36401766)
7. Sutter FK, Simpson JM, Gilles MC: Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 2004; 111: 2044-2049. (Pubitemid 39446723)
8. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A: Intravitreal triamcinolone acetonide for diabetic macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004; 111: 218-225.
9. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Bauernal C: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-927. (Pubitemid 34465226)
10. Verma LK, Vivek MB, Kumar A, Tewari HK, Venkatesh P: A prospective controlled trial to evaluate the adjunctive role of posterior subtenon triamcinolone in the treatment of diffuse diabetic macular edema. J Ocul Pharmacol Ther 2004; 20: 277-284. (Pubitemid 39108892)
11. Chan CK, Mohamed S, Shanmugam MP, et al: Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedema. Br J Ophthalmol 2006; 90: 1137-1141. (Pubitemid 44351145)
12. Lam DS, Chan CK, Mohamed S, Lai TY, Lee VY, Liu DT, Li KK, Li PS, Shanmugam MP: Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: sixmonth outcomes. Ophthalmology 2007; 114: 2162-2167.
13. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME; Pan-American Collaborative Retinal Study Group: Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group. Ophthalmology 2007; 114: 743-750. (Pubitemid 46483714)
14. Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A: Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 2006; 26: 999-1005. (Pubitemid 44973218)
15. Kook D, Wolf A, Kreutzer T, Neubauer A, Struss R, Ulbig M, Kampik A, Haritoglou C: Long-term effect of intravitreal bevacizumab (Avastin) in patients with chronic diffuse diabetic macular edema. Retina 2008; 28: 1053-1060.
16. Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, Bunce C, Leslie RD, Hykin PG: A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study): 12-month data report. Ophthalmology 2010; 117: 1078-1086.
17. Diabetic Retinopathy Clinical Research Network, Elman MJ, Aiello LP, Beck RW, Bressler NM, Bressler SB, Edwards AR, Ferris FL 3rd, Friedman SM, Glassman AR, Miller KM, Scott IU, Stockdale CR, Sun JK: Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010; 117: 1064-1077.
18. Otani T, Kishi S, Maruyama Y: Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999; 127: 688-693. (Pubitemid 29266745)
19. Yamamoto S, Yamamoto T, Hayashi M, Takeuchi S: Morphological and functional analyses of diabetic macular edema by optical coherence tomography and multifocal electroretinograms. Graefes Arch Clin Exp Ophthalmol 2001; 239: 96-101. (Pubitemid 32288458)
20. Kaiser PK, Riemann CD, Sears JE, Lewis H: Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 2001; 131: 44-49. (Pubitemid 32037007)
21. Kang SW, Park CY, Ham DI: The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004; 137: 313-322. (Pubitemid 38221006)
22. Panozzo G, Parolini B, Gusson E, Mercanti A, Pinackatt S, Bertoldo G, Pignatto S: Diabetic macular edema: an OCT-based classification. Semin Ophthalmol 2004; 19: 13-20. (Pubitemid 39658404)
23. Alkuraya H, Kangave D, Abu El-Asrar AM: The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int Ophthalmol 2005; 26: 93-99. (Pubitemid 44781874)
24. Kim BY, Smith SD, Kaiser PK: Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 2006; 142: 405-412.
25. Cunha-Vaz J: Diabetic macular edema. Eur J Ophthalmol 1998; 8: 127-130. (Pubitemid 28459504)
26. Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr: Pathology of human cystoid macular edema. Surv Ophthalmol 1984; 28: 505-511. (Pubitemid 14076510)
27. Lobo C, Bernardes R, Faria de Abreu JR, Cunha-Vaz JG: Novel imaging techniques for diabetic macular edema. Doc Ophthalmol 1999; 97: 341-347.
28. Ferris FL III, Patz A: Macular edema: a complication of diabetic retinopathy. Surv Ophthalmol 1984; 28: 452-461. (Pubitemid 14076504)
29. Fine BS, Brucker AJ: Macular edema and cystoid macular edema. Am J Ophthalmol 1981; 92: 466-481. (Pubitemid 11030201)
30. Yamaguchi Y, Otani T, Kishi S: Resolution of diabetic cystoid macular edema associated with spontaneous vitreofoveal separation. Am J Ophthalmol 2003; 135: 116-118. (Pubitemid 36020445)
31. Shimura M, Nakazawa T, Yasuda K, Shiono T, Iida T, Sakamoto T, Nishida K: Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 2008; 145: 854-861.
32. Catier A, Tadayoni R, Paques M, Erginay A, Haouchine B, Gaudric A, Massin P: Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 2005; 140: 200-206.